Xeris Biopharma Holdings, Inc. (XERS) Weighted Average Number of Shares Outstanding, Basic 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Xeris Biopharma Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2024.
  • Xeris Biopharma Holdings, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2024 was 141 M shares, a 2.46% increase year-over-year.
  • Xeris Biopharma Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 138 M shares, a 1.51% increase from 2022.
  • Xeris Biopharma Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 136 M shares, a 71.6% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 141 M +3.37 M +2.46% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 138 M +2.05 M +1.51% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 138 M +2.11 M +1.55% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 137 M +1.81 M +1.33% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 137 M +2.11 M +1.56% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 136 M +56.6 M +71.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 136 M +69.5 M +104% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 136 M +69.2 M +104% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 135 M +73.8 M +120% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 79 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 66.5 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 66.4 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 61.2 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.